Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Absolutely! .03 break is coming for new 52 week highs. Charts are screaming for a breakout. The constant progress here is absolutely impressive! We should see at least .10 by the end of the year at this pace! $RSII
New product is going to be in production real soon:
Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream.
Haven't sold a single share. .05+ coming $RSII
"Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream."
This means that this product is already created and ready to be made in mass amounts to be distributed on Amazon and other ways...
HUGE news and we haven't even touched base on whats to come of Cannophen and the other cannabis products.
$RSII
.05+
"We are also working with a broker to establish a presence in nationally recognized brick and mortar stores throughout the country.”
Well we know one thing is for sure.. whenever the company says something is going to happen, it sure does!!! I applaud RSII management, there is no other pinky like that. Which may foreshadow that we will soon be looking to uplist.
$RSII News is being leaked all over twitter!!!
https://twitter.com/search?f=tweets&vertical=default&q=%24RSII&src=typd&lang=en
$RSII ask getting pounded!
$RSII News out!!
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®
RSII’s serum ranks among top best-sellers in its category
SANDUSKY, Ohio, May 01, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.'s Rising Biosciences (OTC:RSII) (“RSII” “the Company”), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that Amazon® is now officially stocking and fulfilling orders via Amazon distribution centers throughout the USA for the Company’s revolutionary RSB0238 Clinical Strength Peptide Complex. (product link: https://www.amazon.com/dp/B07CJKTZ2M/ref=cm_sw_r_other_apa_mi31Ab5X0TMAY)
Amazon Prime members receive free two day shipping on the serum, which debuted to 5-star reviews and ranked among the best-selling new releases in the facial serum category.
COO Arthur Hall commented: “This is the first of many RSII products that we’ll be offering via Amazon distribution centers throughout the United States with all order fulfillment performed directly by Amazon. RSII has achieved a highly desirable relationship here, and one we intend to further cultivate. I hope that it is clear to all that this is a monumental achievement for RSII that I believe will propel RSII to the next level of growth. That being said, We are also working with a broker to establish a presence in nationally recognized brick and mortar stores throughout the country.”
Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream.
Hall comments, “It’s safe to say that the anti-aging skin care market is not slowing down anytime soon. The global skin care industry is estimated to reach $131 billion in 2019 and we intend to capture an impactful market share as we continue to innovate and deliver products with unparalleled effect.”
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opioids on America through the responsible use of cannabis”
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
CONTACT INFO:
For Investor Inquiries:
IR@risingbiosciences.com
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e084556d-19e8-47b4-a4fe-2e8f8896ecdc
http://globenewswire.com/news-release/2018/05/01/1494289/0/en/Rising-Biosciences-Announces-Official-Sales-and-Distribution-of-its-RSB0238-Clinical-Strength-Peptide-Complex-on-Amazon.html
$RSII News out!!!
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®
RSII’s serum ranks among top best-sellers in its category
SANDUSKY, Ohio, May 01, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.'s Rising Biosciences (OTC:RSII) (“RSII” “the Company”), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that Amazon® is now officially stocking and fulfilling orders via Amazon distribution centers throughout the USA for the Company’s revolutionary RSB0238 Clinical Strength Peptide Complex. (product link: https://www.amazon.com/dp/B07CJKTZ2M/ref=cm_sw_r_other_apa_mi31Ab5X0TMAY)
Amazon Prime members receive free two day shipping on the serum, which debuted to 5-star reviews and ranked among the best-selling new releases in the facial serum category.
COO Arthur Hall commented: “This is the first of many RSII products that we’ll be offering via Amazon distribution centers throughout the United States with all order fulfillment performed directly by Amazon. RSII has achieved a highly desirable relationship here, and one we intend to further cultivate. I hope that it is clear to all that this is a monumental achievement for RSII that I believe will propel RSII to the next level of growth. That being said, We are also working with a broker to establish a presence in nationally recognized brick and mortar stores throughout the country.”
Rising Biosciences team is thrilled to announce that their next product moving into production is its RBS0346 Clinical Strength Stem Cell Cream.
Hall comments, “It’s safe to say that the anti-aging skin care market is not slowing down anytime soon. The global skin care industry is estimated to reach $131 billion in 2019 and we intend to capture an impactful market share as we continue to innovate and deliver products with unparalleled effect.”
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opioids on America through the responsible use of cannabis”
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
CONTACT INFO:
For Investor Inquiries:
IR@risingbiosciences.com
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e084556d-19e8-47b4-a4fe-2e8f8896ecdc
http://globenewswire.com/news-release/2018/05/01/1494289/0/en/Rising-Biosciences-Announces-Official-Sales-and-Distribution-of-its-RSB0238-Clinical-Strength-Peptide-Complex-on-Amazon.html
Excellent news!! GO $RSII
So are you upset that we will likely hit .10 in the near future? RSII is RSII, not POTN and doesnt have the same pipeline of products nor does it have the same company description as POTN... The sky is the limit here... we are a compound bio company who just so happens to experiment and produce products with cannabis!
$RSII
.05+
As of now, RBS0238 CLINICAL STRENGTH PEPTIDE COMPLEX is available on Amazon and through PAOG's facilities (as noted in yesterday's PAOG tweet/FB message).
We have many other products which will overall create multiple streams of income for RSII. The sky is the limit here! I love that we are a new company and there are many things in the pipelines for where we can go. We are incorporating marijuana and other natural remedies to fight against the opioid abuse epidemic which is making headlines every single day, not just in America, but across most of the globe!
$RSII (RBIO)
Flippers who took nearly 50% gains over the past week are out! Let's move forward now!
.05+
PR is imminent.. who in their right mind would sell before it comes?
We need to know what we own here and what is ahead. Anything below .02 is a steal! IMHO
$RSII (RBIO)
.05+
Knocked those .0155s out of the park! SMART BUYERS HERE!
Lock your shares before the shorters show up! 2 strong green days, they will be here this week! Let's continue the run to .05
PR said to be posted either end of April or beginning of May. They gave us the FB and twitter updates end of April and the PR is imminent, at this moment! $RSII .05+
$RSII ~ PR imminent! Product now on AMAZON:
https://www.amazon.com/RBS0238-CLINICAL-STRENGTH-PEPTIDE-COMPLEX/dp/B07CJKTZ2M/ref=sr_1_1_a_it?ie=UTF8&qid=1524868984&sr=8-1&keywords=RISING+BIOSCIENCES+INC
$PAOG Tweeted on RSII an hour ago:
We would like to announce that PAOG will be carrying all of RSII's products including there newly launched RBS0238 CLINICAL STRENGTH PEPTIDE COMPLEX at all of our clinics
https://twitter.com/paogroup?lang=en
We haven't seen nothin' yet! New 52week highs coming! I can feel it $RSII
Check out the $RSII buzz on Twitter:
https://twitter.com/search?f=tweets&vertical=default&q=%24RSII&src=typd&lang=en
$RSII ~ Beautiful day and nice volume here!
$RSII ~ Hottest stock in the MMJ market!
Sky is the limit here with new developing products! $RSII
I can only imagine how many products we will eventually have on the market by the next year or so... WOW! Talk about revenues and dollar$$$
$RSII ~ MUST WATCH THIS WEEK:
- Product just released on AMAZON
https://www.amazon.com/RBS0238-CLINICAL-STRENGTH-PEPTIDE-COMPLEX/dp/B07CJKTZ2M/ref=sr_1_1_a_it?ie=UTF8&qid=1524868984&sr=8-1&keywords=RISING+BIOSCIENCES+INC
https://globenewswire.com/news-release/2018/04/25/1486866/0/en/Online-Retailing-of-Scar-Treatment-Products-is-a-Major-Trend-in-the-Scar-Treatment-Market-P-S-Market-Research.html
- Still undervalued and oversold
http://stockcharts.com/h-sc/ui
PR about to drop any day now:
We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”
“As well, we have corresponded in regards to the FDA testing procedures on our TSW pain cream and they continue to progress to what we feel will be near-term completion.”
http://risingbiosciences.com/
$RSII ~ MUST WATCH THIS WEEK:
- Product just released on AMAZON
https://www.amazon.com/RBS0238-CLINICAL-STRENGTH-PEPTIDE-COMPLEX/dp/B07CJKTZ2M/ref=sr_1_1_a_it?ie=UTF8&qid=1524868984&sr=8-1&keywords=RISING+BIOSCIENCES+INC
https://globenewswire.com/news-release/2018/04/25/1486866/0/en/Online-Retailing-of-Scar-Treatment-Products-is-a-Major-Trend-in-the-Scar-Treatment-Market-P-S-Market-Research.html
- Still undervalued and oversold
http://stockcharts.com/h-sc/ui
PR about to drop any day now:
We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”
“As well, we have corresponded in regards to the FDA testing procedures on our TSW pain cream and they continue to progress to what we feel will be near-term completion.”
http://risingbiosciences.com/
Everything the company has promised would happen have happened here. They have earned my trust! .05++ $RSII
1 product already on AMAZON!! Ready for revenues, revenues, and more revenues!!!
Wayyy undervalued here! It's time for a name change and re-evaluation of the company! .05+
$RSII
This product just made us legit! All the naysayers... I will see you in nickel land while you get caught chasing! haha! $RSII
Benefits of the serum:
• Helps to decrease the appearance of fine lines ,wrinkles and scars
• Plumps, smooths, and firms the look of skin
• Increases the appearance of elasticity
• Nourishes and hydrates
• Fights Premature Aging
• Combats the Appearance of Fine Lines / Wrinkles
• Provides Deep Nourishment while protecting the skin against dehydration
• Peptides signal the skin to produce additional collagen, working to help reduce loss of volume and elasticity
https://www.amazon.com/gp/product/B07CJKTZ2M?ie=UTF8&camp=213733&creative=393177&creativeASIN=B07CJKTZ2M&linkCode=shr&tag=ustockpicks-20&linkId=XNZPXB5J4PHLNJJ7&s=beauty&qid=1524860121&sr=1-1&keywords=rising+biosciences
$RSII ~ Amazon update out today!! $$$
https://www.facebook.com/RisingBioSciences/
Product has reached Amazon and once received into inventory it will be available Amazon Prime free 2-day shipping
$RSII ~ Amazon update out today!! $$$
https://www.facebook.com/RisingBioSciences/
Product has reached Amazon and once received into inventory it will be available Amazon Prime free 2-day shipping
But the Accum/Dist line has been north on the daily chart, even with the recent PPS dip... There is a significant increase in PPS that is going to occur promptly. Mix it up with catalysts dropping and we have the perfect storm! $RSII .05+
Still OVERSOLD here. We are at RSI 46 right now.
Company quoted this will be a BIG year for $RSII
Remember, the company has a great track record of delivering their promises.
The only thing we have not seen yet is our ticker/name change, and the reason for that is because it is up to FINRA. We have submitted the forms about a year now, and this news could drop at literally any moment!
I am expecting .05+ this year. Haven't seen nothing yet, folks!
The consequential promise of selling the product on amazon was quoted from our last PR that there will be "revenues, revenues, and more revenues."
$RSII
https://globenewswire.com/news-release/2018/03/20/1443055/0/en/Rising-Biosciences-Expedites-Growth-Expansion-with-In-House-Chemist-Laboratory-Analytical-Equipment-and-Producer-Processor-Contracts.html
We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”
Product being sold on amazon... this means one thing, again... our company has continuously kept their word on everything they have told us! This is amazing. WOW
$RSII